{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:41:37Z","timestamp":1790415697582,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objectives<\/jats:title>\n                    <jats:p>Tracking excess adiposity at population scale is essential for managing the obesity pandemic in human populations. New formulas based on weight, height, waist and hip measurements have been suggested as better alternatives to the classic body mass index and waist-hip ratio, but the lack of systematic benchmarking on how these formulas reflect adiposity, metabolic dysfunction and clinical sequelae causes confusion on how to best monitor the health of populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects\/Methods<\/jats:title>\n                    <jats:p>Participants from the Northern Finland Birth Cohort 1966 were included based on data availability at the 46-year visit (2511 women and 1908 men). Cross-sectional sex-adjusted Spearman correlations with clinical biomarkers and serum and urine NMR metabolomics were calculated for body mass index (BMI), waist-hip ratio (WHR), waist-height ratio (WHER), abdominal volume index, body adiposity index, body roundness index, body shape index, conicity index and impedance-based body fat. UK biobank participants were selected based on available data at initial visit (244,947 women and 205,949 men). Prevalent and incident cases of type 2 diabetes, hypertension, liver disease and heart disease were ascertained through register linkage. Prevalent cases were predicted from adiposity measures by age- and sex-adjusted logistic regression and incident cases by age- and sex-adjusted Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Adiposity measures were highly collinear and exhibited low biomolecular specificity. BMI and WHR together captured almost all body shape information related to cardiometabolic diseases. For instance, the c-statistic of the BMI &amp; WHR model for diabetes (0.8012; CI95: 0.7963, 0.8061) was near the theoretical maximum of 0.8047. Diabetes was also predicted by WHER (0.7951; CI95: 0.7903, 0.8000). Other adiposity measures showed equal or worse prediction accuracy. This pattern repeated across multiple disease diagnoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We did not observe sufficient benefits from the more recent body adiposity formulas over body mass index, waist-hip or waist-height ratio to warrant their widespread application in cardiometabolic epidemiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41366-025-01895-2","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T10:24:59Z","timestamp":1758277499000},"page":"2555-2560","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiological associations between obesity, metabolism and disease risk: are body mass index and waist-hip ratio all you need?"],"prefix":"10.1038","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-2656","authenticated-orcid":false,"given":"Ville-Petteri","family":"M\u00e4kinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-7449","authenticated-orcid":false,"given":"Andrei","family":"Ihanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8586-7345","authenticated-orcid":false,"given":"Tuulia","family":"Tynkkynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5905-1206","authenticated-orcid":false,"given":"Mika","family":"Ala-Korpela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"1895_CR1","doi-asserted-by":"publisher","unstructured":"Jayedi A, Soltani S, Motlagh SZ, Emadi A, Shahinfar H, Moosavi H, et al. Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies. BMJ. 2022;e067516. https:\/\/doi.org\/10.1136\/bmj-2021-067516.","DOI":"10.1136\/bmj-2021-067516"},{"key":"1895_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0899-9007(97)00191-3","volume":"13","author":"P Bj\u00f6rntorp","year":"1997","unstructured":"Bj\u00f6rntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition. 1997;13:795\u2013803. https:\/\/doi.org\/10.1016\/S0899-9007(97)00191-3.","journal-title":"Nutrition"},{"key":"1895_CR3","doi-asserted-by":"crossref","unstructured":"Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1\u00b78 million participants. Lancet Lond Engl. 2014;383:970\u201383. 10.1016\/S0140-6736(13)61836-X..","DOI":"10.1016\/S0140-6736(13)61836-X"},{"key":"1895_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41366-023-01281-w","volume":"47","author":"V-P M\u00e4kinen","year":"2023","unstructured":"M\u00e4kinen V-P, Kettunen J, Lehtim\u00e4ki T, K\u00e4h\u00f6nen M, Viikari J, Perola M, et al. Longitudinal metabolomics of increasing body-mass index and waist-hip ratio reveals two dynamic patterns of obesity pandemic. Int J Obes 2005. 2023;47:453\u201362. https:\/\/doi.org\/10.1038\/s41366-023-01281-w.","journal-title":"Int J Obes 2005"},{"key":"1895_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2024.20115","volume":"332","author":"K Schweitzer","year":"2024","unstructured":"Schweitzer K. Could the body roundness index one day replace the BMI?. JAMA. 2024;332:1317 https:\/\/doi.org\/10.1001\/jama.2024.20115.","journal-title":"JAMA"},{"key":"1895_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71302-5","volume":"10","author":"S Christakoudi","year":"2020","unstructured":"Christakoudi S, Tsilidis KK, Muller DC, Freisling H, Weiderpass E, Overvad K, et al. A body shape index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort. Sci Rep. 2020;10:14541. https:\/\/doi.org\/10.1038\/s41598-020-71302-5.","journal-title":"Sci Rep"},{"key":"1895_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41591-024-03299-7","volume":"31","author":"Coral DE","year":"2025","unstructured":"Coral DE, Smit F, Farzaneh A, Gieswinkel A, Fernandez Tajes JF, Spars\u00f8 T, et al. Subclassification of obesity for precision prediction of cardiometabolic diseases. Nat Med. 2025;31:534\u201343. https:\/\/doi.org\/10.1038\/s41591-024-03299-7.","journal-title":"Nat Med"},{"key":"1895_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jcmg.2020.02.031","volume":"14","author":"IJ Neeland","year":"2021","unstructured":"Neeland IJ, Yokoo T, Leinhard OD, Lavie C. 21st Century advances in multimodality imaging of obesity for care of the cardiovascular patient. JACC Cardiovasc Imaging. 2021;14:482\u201394. https:\/\/doi.org\/10.1016\/j.jcmg.2020.02.031.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1895_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diab Endocrinol. 2025;13:221\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","journal-title":"Lancet Diab Endocrinol"},{"key":"1895_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/s41366-018-0285-9","volume":"43","author":"L Becroft","year":"2019","unstructured":"Becroft L, Ooi G, Forsyth A, King S, Tierney A. Validity of multi-frequency bioelectric impedance methods to measure body composition in obese patients: a systematic review. Int J Obes. 2019;43:1497\u2013507. https:\/\/doi.org\/10.1038\/s41366-018-0285-9.","journal-title":"Int J Obes"},{"key":"1895_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69498-7","volume":"10","author":"I Sommer","year":"2020","unstructured":"Sommer I, Teufer B, Szelag M, Nussbaumer-Streit B, Titscher V, Klerings I, et al. The performance of anthropometric tools to determine obesity: a systematic review and meta-analysis. Sci Rep. 2020;10:12699. https:\/\/doi.org\/10.1038\/s41598-020-69498-7.","journal-title":"Sci Rep"},{"key":"1895_CR12","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/ije\/dyab109","volume":"50","author":"T Nordstr\u00f6m","year":"2022","unstructured":"Nordstr\u00f6m T, Miettunen J, Auvinen J, Ala-Mursula L, Kein\u00e4nen-Kiukaanniemi S, Veijola J, et al. Cohort profile: 46 years of follow-up of the Northern Finland Birth Cohort 1966 (NFBC1966). Int J Epidemiol. 2022;50:1786\u20131787j. https:\/\/doi.org\/10.1093\/ije\/dyab109.","journal-title":"Int J Epidemiol"},{"key":"1895_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P W\u00fcrtz","year":"2017","unstructured":"W\u00fcrtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies. Am J Epidemiol. 2017;186:1084\u201396. https:\/\/doi.org\/10.1093\/aje\/kwx016.","journal-title":"Am J Epidemiol"},{"key":"1895_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyad162","volume":"53","author":"T Li","year":"2024","unstructured":"Li T, Ihanus A, Ohukainen P, J\u00e4rvelin M-J, K\u00e4h\u00f6nen M, Kettunen J, et al. Clinical and biochemical associations of urinary metabolites: quantitative epidemiological approach on renal-cardiometabolic biomarkers. Int J Epidemiol. 2024;53:dyad162. https:\/\/doi.org\/10.1093\/ije\/dyad162.","journal-title":"Int J Epidemiol"},{"key":"1895_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40880-4","volume":"9","author":"P Oura","year":"2019","unstructured":"Oura P, Nurkkala M, Auvinen J, Niinim\u00e4ki J, Karppinen J, Junno JA. The association of body size, shape and composition with vertebral size in midlife \u2013 the Northern Finland Birth Cohort 1966 Study. Sci Rep. 2019;9:3944. https:\/\/doi.org\/10.1038\/s41598-019-40880-4.","journal-title":"Sci Rep"},{"key":"1895_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0188-4409(03)00073-0","volume":"34","author":"F Guerrero-Romero","year":"2003","unstructured":"Guerrero-Romero F, Rodr\u0131\u0301guez-Mor\u00e1n M. Abdominal volume index. An anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003;34:428\u201332. https:\/\/doi.org\/10.1016\/S0188-4409(03)00073-0.","journal-title":"Arch Med Res"},{"key":"1895_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/oby.2011.38","volume":"19","author":"RN Bergman","year":"2011","unstructured":"Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, et al. A better index of body adiposity. Obesity. 2011;19:1083\u20139. https:\/\/doi.org\/10.1038\/oby.2011.38.","journal-title":"Obesity"},{"key":"1895_CR18","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/oby.20408","volume":"21","author":"DM Thomas","year":"2013","unstructured":"Thomas DM, Bredlau C, Bosy-Westphal A, Mueller M, Shen W, Gallagher D, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obesity. 2013;21:2264\u201371. https:\/\/doi.org\/10.1002\/oby.20408.","journal-title":"Obesity"},{"key":"1895_CR19","doi-asserted-by":"publisher","first-page":"e39504","DOI":"10.1371\/journal.pone.0039504","volume":"7","author":"NY Krakauer","year":"2012","unstructured":"Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS One. 2012;7:e39504 https:\/\/doi.org\/10.1371\/journal.pone.0039504.","journal-title":"PLoS One"},{"key":"1895_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/0895-4356(91)90059-I","volume":"44","author":"R Valdez","year":"1991","unstructured":"Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991;44:955\u20136. https:\/\/doi.org\/10.1016\/0895-4356(91)90059-I.","journal-title":"J Clin Epidemiol"},{"key":"1895_CR21","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.2337\/db19-1174","volume":"69","author":"MS Nilsen","year":"2020","unstructured":"Nilsen MS, Jersin R\u00c5, Ulvik A, Madsen A, McCann A, Svensson P-A, et al. 3-hydroxyisobutyrate, a strong marker of insulin resistance in type 2 diabetes and obesity that modulates white and brown adipocyte metabolism. Diabetes. 2020;69:1903\u201316. https:\/\/doi.org\/10.2337\/db19-1174.","journal-title":"Diabetes"},{"key":"1895_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/bms.1200131004","volume":"13","author":"DB Kassel","year":"1986","unstructured":"Kassel DB, Martin M, Schall W, Sweeley CC. Urinary metabolites ofL-threonine in type 1 diabetes determined by combined gas chromatography\/chemical ionization mass spectrometry. Biol Mass Spectrom. 1986;13:535\u201340. https:\/\/doi.org\/10.1002\/bms.1200131004.","journal-title":"Biol Mass Spectrom"},{"key":"1895_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/toxins9020052","volume":"9","author":"T Gryp","year":"2017","unstructured":"Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl sulfate. Toxins. 2017;9:52 https:\/\/doi.org\/10.3390\/toxins9020052.","journal-title":"Toxins"},{"key":"1895_CR24","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779 https:\/\/doi.org\/10.1371\/journal.pmed.1001779.","journal-title":"PLoS Med"},{"key":"1895_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/EDE.0000000000001810","volume":"36","author":"P Bohmann","year":"2025","unstructured":"Bohmann P, Stein MJ, Weber A, Konzok J, Fontvieille E, Peruchet-Noray L, et al. Body shapes of multiple anthropometric traits and all-cause and cause-specific mortality in the UK biobank. Epidemiol Camb Mass. 2025;36:264\u201374. https:\/\/doi.org\/10.1097\/EDE.0000000000001810.","journal-title":"Epidemiol Camb Mass"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01895-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:39:34Z","timestamp":1763667574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1895"],"URL":"https:\/\/doi.org\/10.1038\/s41366-025-01895-2","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted on existing datasets that were collected according to local guidelines and regulations that govern biomedical studies and their methodology. The NFBC66 study was approved by the Northern Ostrobothnia Hospital District Ethical Committee, Finland (94\/2011, Dec 12th 2011). The UK Biobank was approved by the North West Multi-centre Research Ethics Committee (21\/NW\/0157, Jun 29th 2021) with details available online [\n                      \n                      ]. All participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}